Product Catalog [{"id":"547","name":"Leqembi","price":1042.88,"sku":"Leqembi (lecanemab-irmb)","brand":"Eisai Europe Ltd","position":1,"category":"Medicines\/Neurology\/Alzheimer's disease"},{"id":"443","name":"Aduhelm","price":1334.88,"sku":"Aduhelm (aducanumab-avwa)","brand":"Biogen","position":2,"category":"Medicines\/Neurology\/Alzheimer's disease"}]

Alzheimer's disease access options

Alzheimer’s disease is a degenerative brain disorder that today affects over 40 million people around the world and is the most common cause of dementia. Believed for many years to be a normal part of aging, Alzheimer’s disease is now recognised as a condition with serious healthcare, economic, and social impacts. Researchers do not yet fully understand what causes Alzheimer’s disease, but it is believed to be caused by a combination of factors, such as aging, family history and other factors such as a link between Alzheimer's and heart disease, diabetes and obesity.
  1. Aduhelm
    Aduhelm (aducanumab-avwa)
    Alzheimer's disease
  2. Leqembi
    Leqembi (lecanemab-irmb)
    Alzheimer's disease
View as Grid List

2 Items

Set Descending Direction
Read more about the latest treatments in Alzheimer's disease
US 0